These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 7614506)
21. [Modification of hemodynamics by angiotensin converting enzyme inhibitors in heart failure]. Ertl G; Gaudron P; Eilles C Herz; 1990 Jun; 15(3):158-63. PubMed ID: 2198216 [TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme inhibitors in heart failure: new strategies justified by recent clinical trials. Young JB Int J Cardiol; 1994 Feb; 43(2):151-63. PubMed ID: 8181869 [TBL] [Abstract][Full Text] [Related]
23. Underutilization of angiotensin-converting enzyme inhibitors in older patients with Q-wave anterior myocardial infarction in an academic hospital-based geriatrics practice. Mendelson G; Aronow WS J Am Geriatr Soc; 1998 Jun; 46(6):751-2. PubMed ID: 9625192 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic role of angiotensin II receptor blockers in the treatment of heart failure. Manohar P; Piña IL Mayo Clin Proc; 2003 Mar; 78(3):334-8. PubMed ID: 12630586 [TBL] [Abstract][Full Text] [Related]
25. A comparison of intervention with losartan or captopril in acute myocardial infarction. Spinar J; Vitovec J; Spinarova L; Pluhacek L; Fischerova B; Toman J Eur J Heart Fail; 2000 Mar; 2(1):91-100. PubMed ID: 10742708 [TBL] [Abstract][Full Text] [Related]
26. Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing. Andersson F; Cline C; Rydén-Bergsten T; Erhardt L Pharmacoeconomics; 1999 Jun; 15(6):535-50. PubMed ID: 10538327 [TBL] [Abstract][Full Text] [Related]
33. Do ACE inhibitors provide protection for the heart in the clinical setting of acute myocardial infarction? Megarry SG; Sapsford R; Hall AS; Ball SG Drugs; 1997; 54 Suppl 5():48-58. PubMed ID: 9429845 [TBL] [Abstract][Full Text] [Related]
34. What is the role of angiotensin-converting enzyme inhibitors in congestive heart failure and after myocardial infarction? Nelson KM; Yeager BF Ann Pharmacother; 1996 Sep; 30(9):986-93. PubMed ID: 8876861 [TBL] [Abstract][Full Text] [Related]
35. Angiotensin-converting enzyme inhibitor use in elderly patients hospitalized with heart failure and left ventricular systolic dysfunction. Rangaswamy C; Finn JI; Koelling TM Cardiology; 2005; 103(1):17-23. PubMed ID: 15528896 [TBL] [Abstract][Full Text] [Related]
36. [Indications for ACE inhibitors in the postinfarct period]. Ertl G; Gaudron P; Neubauer S; Hu K; Zdrojewski T; Horn M; Kochsiek K Z Kardiol; 1994; 83 Suppl 4():65-74. PubMed ID: 7856283 [TBL] [Abstract][Full Text] [Related]
37. ACE-inhibition and angiotensin II receptor blockers in chronic heart failure: pathophysiological consideration of the unresolved battle. Simko F; Simko J; Fabryova M Cardiovasc Drugs Ther; 2003 May; 17(3):287-90. PubMed ID: 14669746 [TBL] [Abstract][Full Text] [Related]
38. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials. Tokmakova M; Solomon SD Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193 [TBL] [Abstract][Full Text] [Related]
39. Current controversies with ACE inhibitor treatment in heart failure. Visser FC; Visser CA Cardiology; 1996; 87 Suppl 1():23-8. PubMed ID: 8681318 [TBL] [Abstract][Full Text] [Related]
40. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]